Sepranolone

N/A

Report date: 2026/05/15 20:01:45
NME

Base Information

Drug NameSepranolone
Drug Alias NameIsoallopregnanolone塞帕诺龙塞普诺龙Epiallopregnanolone3beta-Allopregnanolone +[10] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGamma-aminobutyric acid A receptor antagonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsPremenstrual Dysphoric DisorderMigraine DisordersTourette Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenPolandDenmark +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesKarolinska Development (Kdev)
China Registration ClassN/A

Develop Information

Active CompaniesAsarina PharmaKarolinska Development (Kdev)Relmada Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMigraine DisordersTourette Syndrome
Inactive IndicationsPremenstrual Dysphoric Disorder

Other Information

ATC CodeN/A
Related LinksWikipedia